Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL31P24 (ribosomal protein L31 pseudogene 24) is a human pseudogene identified in genomic DNA corresponding to the gene for ribosomal protein L31. Unlike functional ribosomal protein genes, RPL31P24 does not encode a protein and is generally not transcribed or translated. Pseudogenes are sequences in the genome that resemble known genes but typically contain mutations or deletions that prevent them from producing functional proteins. RPL31P24 is mentioned in gene databases and scientific product catalogs because of its genomic presence, but it is not biologically active and has no documented role as a therapeutic target or in disease mechanism[5][7][8][9][11].
None (No mechanisms of drug action relevant to this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 24 (RPL31P24).